論文

国際誌
2016年12月30日

Peripherally administered orexin improves survival of mice with endotoxin shock.

eLife
  • Yasuhiro Ogawa
  • Yoko Irukayama-Tomobe
  • Nobuyuki Murakoshi
  • Maiko Kiyama
  • Yui Ishikawa
  • Naoto Hosokawa
  • Hiromu Tominaga
  • Shuntaro Uchida
  • Saki Kimura
  • Mika Kanuka
  • Miho Morita
  • Michito Hamada
  • Satoru Takahashi
  • Yu Hayashi
  • Masashi Yanagisawa
  • 全て表示

5
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.7554/eLife.21055

Sepsis is a systemic inflammatory response to infection, accounting for the most common cause of death in intensive care units. Here, we report that peripheral administration of the hypothalamic neuropeptide orexin improves the survival of mice with lipopolysaccharide (LPS) induced endotoxin shock, a well-studied septic shock model. The effect is accompanied by a suppression of excessive cytokine production and an increase of catecholamines and corticosterone. We found that peripherally administered orexin penetrates the blood-brain barrier under endotoxin shock, and that central administration of orexin also suppresses the cytokine production and improves the survival, indicating orexin's direct action in the central nervous system (CNS). Orexin helps restore body temperature and potentiates cardiovascular function in LPS-injected mice. Pleiotropic modulation of inflammatory response by orexin through the CNS may constitute a novel therapeutic approach for septic shock.

リンク情報
DOI
https://doi.org/10.7554/eLife.21055
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/28035899
PubMed Central
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5245965
ID情報
  • DOI : 10.7554/eLife.21055
  • PubMed ID : 28035899
  • PubMed Central 記事ID : PMC5245965

エクスポート
BibTeX RIS